plasma
-
not specified
RT-qPCR; Clinical Sample Validation; Cohort Study; ROC Analysis
Low plasma circRAD18 on the day of pregnancy confirmation distinguishes potential GDM patients from non-GDM cases and predicts GDM and hypertension.
Plasma circRAD18 levels are decreased at pregnancy confirmation in women who later develop GDM. Low plasma circRAD18 serves as a potential early biomarker predicting GDM risk and is associated with subsequent hypertension.
0.4758
The application of plasma circRAD18 in the prediction of gestational diabetes mellitus (GDM) and its adverse effects.
clinical study